CryoLife Heart Valves a Risk, FDA Says
- Share via
Bloomberg News
CryoLife Inc.’s heart valves may carry a risk of infection for patients, so doctors should consider using other suppliers if possible, the Food and Drug Administration said.
CryoLife’s heart valves weren’t part of a recall earlier this month the FDA ordered for some of the company’s products earlier this month.
CryoLife officials couldn’t be reached for comment. CryoLife shares fell 29 cents to $3.68 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
